ArticleMolecular medicine (Cambridge, Mass.)2025

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.

Jiawan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.